Although C4 concentration testing was performed in the primary screening panel by MS/MS, metabolic disorders associated with elevated C4, such as SCADD and IBDD, are difficult to distinguish by initial NBS screening. The gene discussed is C4A; the disease is short chain acyl-CoA dehydrogenase deficiency.